For Covid-19 related information, please refer to the Ministry of Health and Family Welfare Website
Dr. Moushumi Suryavanshi


MBBS, MD (Pathology)

Senior Consultant-Molecular Diagnostics

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

SPECIALIZED AREAS

Liquid Biopsy(Cell free DNA & Circulating Tumor Cells)
Next Generation Sequencing
Fluorescent Insitu Hybridization
Pyrosequencing
Real Time PCR

EDUCATIONAL BACKGROUND

Pursing PhD in Cellular & Molecular Oncology
M.D. - Pathology, DMC, Ludhiana
M.B.B.S. - Govt. Medical College, Patiala

EXPERIENCES

Senior Consultant, Molecular Diagnostics, RGCI &RC- Till date
Consultant Oncopathology ,RGCI&RC- 3 years
Worked as Senior Consultant in Lal Path Labs - Reference Lab, Rohini Histocytopathology -4 years
Worked as Lecturer at Seth GS medical college& KEM hospital, Mumbai - 3 years
Lecturer-Pamshree Dr DY Patil Hospital, Mumbai- 8 months
Worked as Senior resident at Safdarjung hospital and UCMS New Delhi
Member of Indian Association of Pathologist and Microbiologist
Member of International Academy of Pathology -Indian Division

MEMBERSHIPS

ASCO
IASLC
International society of urological Pathology
Indian network of uropathology
European network of uropathology

ABOUT

Dr Moushumi's Suryavanshi has been a pathologist with special interest in Genitourinary Pathology. She has been a part of ISUP grading committee which has given the new 2016 WHO classification for prostate cancer.
Currently, she is managing Molecular Diagnostics at Rajiv Cancer Institute & Research Centre. The molecular centre at RGCI & RC has state of art facilities like Next Generation sequencing, Circulating tumor cells, Cell free DNA, Pyrosequencing, Flowcytometry, FISH and real time PCR.
She is also pursuing a PhD in Molecular & Cellular oncology.

PROFESSIONAL JOURNEY

ACHIEVEMENTS
BRCA mutations reported to NCBI (PUBMED)
NABL Assessor
Member of ISUP grading Committee for Prostate Cancer in 2014
Lead Coordinator of Indian Network of uropathology.
PUBLICATIONS
S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers. Suryavanshi M, Sanz-Ortega J, Sirohi D, Divatia MK, Ohe C, Zampini C, Luthringer D, Smith SC, Amin MB. Adv Anat Pathol. 2017 May;24(3):151-160. doi: 10.1097/PAP.0000000000000150. Review.PMID:28398953
BRCA mutations reported to NCBI (PUBMED) ,Clinvar
MET Amplification and Response to MET Inhibitors in Stage IV Lung Adenocarcinoma. Suryavanshi M, Shah A, Kumar D, Panigrahi MK, Metha A, Batra U.Oncol Res Treat. 2017;40(4):198-202. doi: 10.1159/000457801. Epub 2017 Mar 8.PMID: 28324883
Detection of false positive mutations in BRCA gene by next generation sequencing. Moushumi Suryavanshi1 "¢ Dushyant Kumar1 "¢ Manoj Kumar Panigrahi1 "¢ Meenakshi Chowdhary "¢ Anurag Mehta. Familial Cancer DOI 10.1007/s10689-016-9955-8
ROS1 Gene Rearrangement Positive Non Small cell Lung Cancer. Doval DC, Sinha R, Suryavanshi M, Choudhury KD, Sharma A, Choudhury PS, Meta A. Journal of Case Reports 2017;7(1):13-15
Circulating Rumor Cells in Breast Cancer. Akhil Jain, Moushumi Suryavanshi, Ullas Batra, Pankaj Goyal, Dinesh Doval. International Journal of Molecular & ImmunoOncology . Jan 2017 Online ISSN: 2456-3994
Role of Crizotinib in C-MET positive Non Small Cell Lung Cancer Patients-A case Series. Indian Journal of Cancer. Ullas Batra, Manish Sharma , Rajat Bajaj & Moushumi Suryavanshi
Quantification of DNA Extracted from Formalin Fixed Paraffin-Embeded Tissue Comparison of Three Techniques: Effect on PCR Efficiency. Kumar D, Panigrahi MK, Suryavanshi M, Mehta A, Saikia KK.J Clin Diagn Res. 2016 Sep;10(9):BC01-BC03. Epub 2016 Sep 1.PMID:27790419
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee.Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Review.
Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook.Suryavanshi M, Mehta A, Jaipuria J, Sharma AK, Rawal S, Seth N.Urol Oncol. 2015 Jul;33(7):331.e9-15. doi: 10.1016/j.urolonc.2015.03.017. Epub 2015 Apr 17.
Thrombocytopenia in leptospirosis and role of platelet transfusion.Sharma J, Suryavanshi M. Asian J Transfus Sci. 2007 Jul;1(2):52-5. doi: 10.4103/0973-6247.33447
Register Now